Consistent with these findings, follistatin suppressed metastasis in mouse breast and lung cancer models (Ogino et al, 2008; Seachrist et al, 2017) and improved the efficacy of platinum chemotherapy in the management of activin A‐induced lung adenocarcinoma (Marini et al, 2018). This evidence concerns the gene FST and lung carcinoma.